ICAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD To Lead Post-Market Study For Treatment Of Recurrent Glioblastoma (GBM) With FDA-cleared Xoft Brain IORT Technology To Support Clinical Adoption

Press/Media

Period29 Dec 2020

Media coverage

16

Media coverage